| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Options Exercise | $0 | +2,676 | +11% | $0 | 28,140 | 01 Feb 2022 | Direct | |
| transaction | LLY | Common Stock | Tax liability | -$292,995 | -1,194 | -4.2% | $245.39 | 26,946 | 01 Feb 2022 | Direct | |
| holding | LLY | Common Stock | 128 | 01 Feb 2022 | by partner | F1 | |||||
| holding | LLY | Common Stock | 2,675 | 01 Feb 2022 | 401(k) - by partner | F1 | |||||
| holding | LLY | Common Stock | 514 | 01 Feb 2022 | 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -2,676 | -100% | $0* | 0 | 01 Feb 2022 | Common Stock | 2,676 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reporting person disclaims beneficial ownership of these shares. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |